140 related articles for article (PubMed ID: 32881892)
1. Low-frequency variation near common germline susceptibility loci are associated with risk of Ewing sarcoma.
Lin SH; Sampson JN; Grünewald TGP; Surdez D; Reynaud S; Mirabeau O; Karlins E; Rubio RA; Zaidi S; Grossetête-Lalami S; Ballet S; Lapouble E; Laurence V; Michon J; Pierron G; Kovar H; Kontny U; González-Neira A; Alonso J; Patino-Garcia A; Corradini N; Bérard PM; Miller J; Freedman ND; Rothman N; Carter BD; Dagnall CL; Burdett L; Jones K; Manning M; Wyatt K; Zhou W; Yeager M; Cox DG; Hoover RN; Khan J; Armstrong GT; Leisenring WM; Bhatia S; Robison LL; Kulozik AE; Kriebel J; Meitinger T; Metzler M; Krumbholz M; Hartmann W; Strauch K; Kirchner T; Dirksen U; Mirabello L; Tucker MA; Tirode F; Morton LM; Chanock SJ; Delattre O; Machiela MJ
PLoS One; 2020; 15(9):e0237792. PubMed ID: 32881892
[TBL] [Abstract][Full Text] [Related]
2. Germline Variation and Somatic Alterations in Ewing Sarcoma.
Machiela MJ; Grünewald TGP
Methods Mol Biol; 2021; 2226():3-14. PubMed ID: 33326089
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of polymorphisms in EWSR1 and risk of Ewing sarcoma: a report from the Childhood Cancer Survivor Study.
DuBois SG; Goldsby R; Segal M; Woo J; Copren K; Kane JP; Pullinger CR; Matthay KK; Witte J; Lessnick SL; Robison LL; Bhatia S; Strong LC
Pediatr Blood Cancer; 2012 Jul; 59(1):52-6. PubMed ID: 21793187
[TBL] [Abstract][Full Text] [Related]
4. Common variants near TARDBP and EGR2 are associated with susceptibility to Ewing sarcoma.
Postel-Vinay S; Véron AS; Tirode F; Pierron G; Reynaud S; Kovar H; Oberlin O; Lapouble E; Ballet S; Lucchesi C; Kontny U; González-Neira A; Picci P; Alonso J; Patino-Garcia A; de Paillerets BB; Laud K; Dina C; Froguel P; Clavel-Chapelon F; Doz F; Michon J; Chanock SJ; Thomas G; Cox DG; Delattre O
Nat Genet; 2012 Feb; 44(3):323-7. PubMed ID: 22327514
[TBL] [Abstract][Full Text] [Related]
5. Chimeric EWSR1-FLI1 regulates the Ewing sarcoma susceptibility gene EGR2 via a GGAA microsatellite.
Grünewald TG; Bernard V; Gilardi-Hebenstreit P; Raynal V; Surdez D; Aynaud MM; Mirabeau O; Cidre-Aranaz F; Tirode F; Zaidi S; Perot G; Jonker AH; Lucchesi C; Le Deley MC; Oberlin O; Marec-Bérard P; Véron AS; Reynaud S; Lapouble E; Boeva V; Rio Frio T; Alonso J; Bhatia S; Pierron G; Cancel-Tassin G; Cussenot O; Cox DG; Morton LM; Machiela MJ; Chanock SJ; Charnay P; Delattre O
Nat Genet; 2015 Sep; 47(9):1073-8. PubMed ID: 26214589
[TBL] [Abstract][Full Text] [Related]
6. Clinical and biochemical function of polymorphic NR0B1 GGAA-microsatellites in Ewing sarcoma: a report from the Children's Oncology Group.
Monument MJ; Johnson KM; McIlvaine E; Abegglen L; Watkins WS; Jorde LB; Womer RB; Beeler N; Monovich L; Lawlor ER; Bridge JA; Schiffman JD; Krailo MD; Randall RL; Lessnick SL
PLoS One; 2014; 9(8):e104378. PubMed ID: 25093581
[TBL] [Abstract][Full Text] [Related]
7. CD99 polymorphisms significantly influence the probability to develop Ewing sarcoma in earlier age and patient disease progression.
Martinelli M; Parra A; Scapoli L; De Sanctis P; Chiadini V; Hattinger C; Picci P; Zucchini C; Scotlandi K
Oncotarget; 2016 Nov; 7(47):77958-77967. PubMed ID: 27792997
[TBL] [Abstract][Full Text] [Related]
8. DNA methylation profiling distinguishes Ewing-like sarcoma with EWSR1-NFATc2 fusion from Ewing sarcoma.
Koelsche C; Kriegsmann M; Kommoss FKF; Stichel D; Kriegsmann K; Vokuhl C; Grünewald TGP; Romero-Pérez L; Kirchner T; de Alava E; Diaz-Martin J; Hartmann W; Baumhoer D; Antonescu CR; Szuhai K; Flucke U; Dirksen U; Pfister SM; Jones DTW; Mechtersheimer G; von Deimling A
J Cancer Res Clin Oncol; 2019 May; 145(5):1273-1281. PubMed ID: 30895378
[TBL] [Abstract][Full Text] [Related]
9. Hippo pathway effectors YAP1/TAZ induce an EWS-FLI1-opposing gene signature and associate with disease progression in Ewing sarcoma.
Rodríguez-Núñez P; Romero-Pérez L; Amaral AT; Puerto-Camacho P; Jordán C; Marcilla D; Grünewald TG; Alonso J; de Alava E; Díaz-Martín J
J Pathol; 2020 Apr; 250(4):374-386. PubMed ID: 31880317
[TBL] [Abstract][Full Text] [Related]
10. Reversible LSD1 inhibition interferes with global EWS/ETS transcriptional activity and impedes Ewing sarcoma tumor growth.
Sankar S; Theisen ER; Bearss J; Mulvihill T; Hoffman LM; Sorna V; Beckerle MC; Sharma S; Lessnick SL
Clin Cancer Res; 2014 Sep; 20(17):4584-97. PubMed ID: 24963049
[TBL] [Abstract][Full Text] [Related]
11. High-throughput RNAi screen in Ewing sarcoma cells identifies leucine rich repeats and WD repeat domain containing 1 (LRWD1) as a regulator of EWS-FLI1 driven cell viability.
He T; Surdez D; Rantala JK; Haapa-Paananen S; Ban J; Kauer M; Tomazou E; Fey V; Alonso J; Kovar H; Delattre O; Iljin K
Gene; 2017 Jan; 596():137-146. PubMed ID: 27760381
[TBL] [Abstract][Full Text] [Related]
12. The second European interdisciplinary Ewing sarcoma research summit--A joint effort to deconstructing the multiple layers of a complex disease.
Kovar H; Amatruda J; Brunet E; Burdach S; Cidre-Aranaz F; de Alava E; Dirksen U; van der Ent W; Grohar P; Grünewald TG; Helman L; Houghton P; Iljin K; Korsching E; Ladanyi M; Lawlor E; Lessnick S; Ludwig J; Meltzer P; Metzler M; Mora J; Moriggl R; Nakamura T; Papamarkou T; Radic Sarikas B; Rédini F; Richter GH; Rossig C; Schadler K; Schäfer BW; Scotlandi K; Sheffield NC; Shelat A; Snaar-Jagalska E; Sorensen P; Stegmaier K; Stewart E; Sweet-Cordero A; Szuhai K; Tirado OM; Tirode F; Toretsky J; Tsafou K; Üren A; Zinovyev A; Delattre O
Oncotarget; 2016 Feb; 7(8):8613-24. PubMed ID: 26802024
[TBL] [Abstract][Full Text] [Related]
13. Review: Ewing Sarcoma Predisposition.
Gargallo P; Yáñez Y; Juan A; Segura V; Balaguer J; Torres B; Oltra S; Castel V; Cañete A
Pathol Oncol Res; 2020 Oct; 26(4):2057-2066. PubMed ID: 31656020
[TBL] [Abstract][Full Text] [Related]
14. Brain tumor risk according to germ-line variation in the MLLT10 locus.
Egan KM; Baskin R; Nabors LB; Thompson RC; Olson JJ; Browning JE; Madden MH; Monteiro AN
Eur J Hum Genet; 2015 Jan; 23(1):132-4. PubMed ID: 24755950
[TBL] [Abstract][Full Text] [Related]
15. Association between the European GWAS-identified susceptibility locus at chromosome 4p16 and the risk of atrial septal defect: a case-control study in Southwest China and a meta-analysis.
Zhao L; Li B; Dian K; Ying B; Lu X; Hu X; An Q; Chen C; Huang C; Tan B; Qin L
PLoS One; 2015; 10(4):e0123959. PubMed ID: 25875170
[TBL] [Abstract][Full Text] [Related]
16. A novel oncogenic mechanism in Ewing sarcoma involving IGF pathway targeting by EWS/Fli1-regulated microRNAs.
McKinsey EL; Parrish JK; Irwin AE; Niemeyer BF; Kern HB; Birks DK; Jedlicka P
Oncogene; 2011 Dec; 30(49):4910-20. PubMed ID: 21643012
[TBL] [Abstract][Full Text] [Related]
17. EWS-ETS oncoproteins: the linchpins of Ewing tumors.
Janknecht R
Gene; 2005 Dec; 363():1-14. PubMed ID: 16202544
[TBL] [Abstract][Full Text] [Related]
18. Ewing sarcoma with FEV gene rearrangements is a rare subset with predilection for extraskeletal locations and aggressive behavior.
Tsuda Y; Dickson BC; Swanson D; Sung YS; Zhang L; Meyers P; Healey JH; Antonescu CR
Genes Chromosomes Cancer; 2020 May; 59(5):286-294. PubMed ID: 31756779
[TBL] [Abstract][Full Text] [Related]
19. Genetic variants associated with idiopathic pulmonary fibrosis susceptibility and mortality: a genome-wide association study.
Noth I; Zhang Y; Ma SF; Flores C; Barber M; Huang Y; Broderick SM; Wade MS; Hysi P; Scuirba J; Richards TJ; Juan-Guardela BM; Vij R; Han MK; Martinez FJ; Kossen K; Seiwert SD; Christie JD; Nicolae D; Kaminski N; Garcia JGN
Lancet Respir Med; 2013 Jun; 1(4):309-317. PubMed ID: 24429156
[TBL] [Abstract][Full Text] [Related]
20. Genetic analyses identify evidence for a causal relationship between Ewing sarcoma and hernias.
Yang T; Mills LJ; Hubbard AK; Cao R; Raduski A; Machiela MJ; Spector LG
HGG Adv; 2024 Jan; 5(1):100254. PubMed ID: 37919896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
